18f Fluorocholine Cis Bio International

18F Fluorocholine (Chloride) from Cis Bio International is a radiopharmaceutical used in PET imaging for detecting prostate cancer. This EU-sourced agent helps visualize choline metabolism in tissues. Short half-life ensures rapid clearance. Ideal for targeted diagnostic procedures.

18F Fluorocholine is primarily used in positron emission tomography (PET) scans to identify prostate cancer, particularly in cases of biochemical recurrence. It may also assist in imaging certain other cancers where choline metabolism is elevated. The radiotracer helps clinicians locate abnormal tissue by highlighting areas of increased metabolic activity. It is not a treatment but a diagnostic aid.

After intravenous administration, 18F Fluorocholine circulates in the body and accumulates in tissues with high choline uptake, such as some cancer cells. The PET scanner detects the emitted positrons to create detailed images. Patients typically experience no immediate physical effects from the radiotracer itself, though the imaging process may require lying still for a period.

This radiopharmaceutical should only be handled and administered by trained medical professionals in a controlled clinical setting. Pregnant or breastfeeding individuals should avoid exposure due to radiation risks. Patients are advised to stay hydrated and empty their bladder frequently post-procedure to reduce radiation dose. Inform your healthcare provider of any recent imaging or radiation treatments.

No specific drug interactions are widely documented for 18F Fluorocholine, as it is used diagnostically and not systemically. However, medications affecting choline metabolism could theoretically influence uptake in tissues. Alcohol and certain dietary supplements are generally avoided before imaging to ensure clear results. Always disclose all medications and supplements to your healthcare provider prior to the scan.